questionsmedicales.fr
Cellules
Neurones
Neurofibres myélinisées
Neurofibres myélinisées : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Neuropathie
Électromyographie
Imagerie par résonance magnétique
Myéline
Symptômes neurologiques
Douleur
Tests génétiques
Neuropathies héréditaires
Antécédents médicaux
Facteurs de risque
Symptômes
5
Neuropathie
Symptômes neurologiques
Évolution des symptômes
Neuropathie
Prévention
5
Prévention
Maladies chroniques
Prévention des blessures
Traumatismes
Traitements
5
Traitement
Physiothérapie
Analgésiques
Anticonvulsivants
Physiothérapie
Réhabilitation
Médecine alternative
Acupuncture
Médecine personnalisée
Traitement
Complications
5
Complications
Douleurs chroniques
Gestion des complications
Équipe multidisciplinaire
Facteurs de risque
5
Facteurs de risque
Diabète
Hérédité
Neuropathies héréditaires
Vieillissement
Neuropathie
Maladies auto-immunes
Sclérose en plaques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Neurofibres myélinisées : Questions médicales les plus fréquentes",
"headline": "Neurofibres myélinisées : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Neurofibres myélinisées : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-09",
"dateModified": "2025-05-04",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Neurofibres myélinisées"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Neurones",
"url": "https://questionsmedicales.fr/mesh/D009474",
"about": {
"@type": "MedicalCondition",
"name": "Neurones",
"code": {
"@type": "MedicalCode",
"code": "D009474",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres myélinisées",
"alternateName": "Nerve Fibers, Myelinated",
"code": {
"@type": "MedicalCode",
"code": "D009413",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "S E Avetisov",
"url": "https://questionsmedicales.fr/author/S%20E%20Avetisov",
"affiliation": {
"@type": "Organization",
"name": "Krasnov Research Institute of Eye Diseases, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "Z V Surnina",
"url": "https://questionsmedicales.fr/author/Z%20V%20Surnina",
"affiliation": {
"@type": "Organization",
"name": "Krasnov Research Institute of Eye Diseases, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "Yang Shen",
"url": "https://questionsmedicales.fr/author/Yang%20Shen",
"affiliation": {
"@type": "Organization",
"name": "Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China."
}
},
{
"@type": "Person",
"name": "Xingtao Zhou",
"url": "https://questionsmedicales.fr/author/Xingtao%20Zhou",
"affiliation": {
"@type": "Organization",
"name": "Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China."
}
},
{
"@type": "Person",
"name": "Markus Axer",
"url": "https://questionsmedicales.fr/author/Markus%20Axer",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neuroscience and Medicine (INM-1), Forschungszentrum Jülich GmbH, 52425, Jülich, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Neuropsychology and Movement Disorders.",
"datePublished": "2024-06-17",
"url": "https://questionsmedicales.fr/article/39343477",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ncl.2024.05.008"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cannabinoids in movement disorders.",
"datePublished": "2022-08-24",
"url": "https://questionsmedicales.fr/article/36038457",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.parkreldis.2022.08.014"
}
},
{
"@type": "ScholarlyArticle",
"name": "Moving Beyond Movement: Diagnosing Functional Movement Disorder.",
"datePublished": "2023-03-09",
"url": "https://questionsmedicales.fr/article/36893796",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/s-0043-1763505"
}
},
{
"@type": "ScholarlyArticle",
"name": "Impaired Metacognition of Voluntary Movement in Functional Movement Disorder.",
"datePublished": "2023-01-06",
"url": "https://questionsmedicales.fr/article/36606550",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/mds.29303"
}
},
{
"@type": "ScholarlyArticle",
"name": "Movement disorders in COVID-19 times: impact on care in movement disorders and Parkinson disease.",
"datePublished": "2022-07-05",
"url": "https://questionsmedicales.fr/article/35787539",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/WCO.0000000000001075"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Cellules",
"item": "https://questionsmedicales.fr/mesh/D002477"
},
{
"@type": "ListItem",
"position": 3,
"name": "Neurones",
"item": "https://questionsmedicales.fr/mesh/D009474"
},
{
"@type": "ListItem",
"position": 4,
"name": "Neurofibres myélinisées",
"item": "https://questionsmedicales.fr/mesh/D009413"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Neurofibres myélinisées - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Neurofibres myélinisées",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Neurofibres myélinisées",
"description": "Comment diagnostiquer une neuropathie myélinisée ?\nQuels tests d'imagerie sont utilisés ?\nQuels signes cliniques indiquent une atteinte myélinisée ?\nPeut-on détecter des anomalies génétiques ?\nQuel rôle joue l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D009413?mesh_terms=Movement+Disorders#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Neurofibres myélinisées",
"description": "Quels sont les symptômes courants des neuropathies myélinisées ?\nLes symptômes varient-ils selon l'âge ?\nComment les symptômes évoluent-ils ?\nY a-t-il des symptômes spécifiques à surveiller ?\nLes symptômes affectent-ils la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D009413?mesh_terms=Movement+Disorders#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Neurofibres myélinisées",
"description": "Peut-on prévenir les neuropathies myélinisées ?\nQuel rôle joue le mode de vie dans la prévention ?\nLes vaccinations peuvent-elles aider ?\nComment éviter les blessures nerveuses ?\nLe stress a-t-il un impact sur la santé nerveuse ?",
"url": "https://questionsmedicales.fr/mesh/D009413?mesh_terms=Movement+Disorders#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Neurofibres myélinisées",
"description": "Quels traitements sont disponibles pour les neuropathies myélinisées ?\nLes médicaments peuvent-ils soulager la douleur ?\nLa physiothérapie est-elle bénéfique ?\nY a-t-il des traitements alternatifs ?\nLes traitements sont-ils personnalisés ?",
"url": "https://questionsmedicales.fr/mesh/D009413?mesh_terms=Movement+Disorders#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Neurofibres myélinisées",
"description": "Quelles complications peuvent survenir ?\nLes neuropathies peuvent-elles entraîner des handicaps ?\nY a-t-il un risque accru de chutes ?\nLes complications peuvent-elles affecter la santé mentale ?\nComment gérer les complications ?",
"url": "https://questionsmedicales.fr/mesh/D009413?mesh_terms=Movement+Disorders#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Neurofibres myélinisées",
"description": "Quels sont les principaux facteurs de risque ?\nL'hérédité joue-t-elle un rôle ?\nLe vieillissement est-il un facteur de risque ?\nLes maladies auto-immunes sont-elles un risque ?\nLe mode de vie influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D009413?mesh_terms=Movement+Disorders#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une neuropathie myélinisée ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un électromyogramme (EMG) et des études de conduction nerveuse sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels tests d'imagerie sont utilisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IRM peut aider à visualiser les lésions nerveuses et la myéline."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une atteinte myélinisée ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des engourdissements, des faiblesses ou des douleurs peuvent indiquer cela."
}
},
{
"@type": "Question",
"name": "Peut-on détecter des anomalies génétiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests génétiques peuvent identifier des mutations liées à des neuropathies."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à identifier des maladies sous-jacentes ou des facteurs de risque."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des neuropathies myélinisées ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Engourdissements, picotements, douleurs, faiblesse musculaire et réflexes diminués."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent être plus prononcés chez les personnes âgées."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent s'aggraver progressivement ou apparaître par poussées selon la cause."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques à surveiller ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs intenses ou une perte de fonction soudaine nécessitent une attention médicale."
}
},
{
"@type": "Question",
"name": "Les symptômes affectent-ils la qualité de vie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent limiter les activités quotidiennes et affecter le bien-être général."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les neuropathies myélinisées ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines neuropathies peuvent être évitées en contrôlant les maladies sous-jacentes."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le mode de vie dans la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, est crucial."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles aider ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines vaccinations préviennent des infections pouvant causer des neuropathies."
}
},
{
"@type": "Question",
"name": "Comment éviter les blessures nerveuses ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les positions prolongées et les traumatismes peut réduire le risque."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur la santé nerveuse ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut aggraver les symptômes nerveux et affecter la santé."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les neuropathies myélinisées ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la médication, la physiothérapie et parfois la chirurgie."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils soulager la douleur ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des analgésiques et des anticonvulsivants sont souvent prescrits."
}
},
{
"@type": "Question",
"name": "La physiothérapie est-elle bénéfique ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle aide à améliorer la force musculaire et la coordination."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements alternatifs ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des approches comme l'acupuncture peuvent être envisagées, mais avec prudence."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements sont adaptés selon la cause et la gravité des symptômes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent la perte de fonction, des douleurs chroniques et des infections."
}
},
{
"@type": "Question",
"name": "Les neuropathies peuvent-elles entraîner des handicaps ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des neuropathies sévères peuvent entraîner des handicaps fonctionnels significatifs."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de chutes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la faiblesse musculaire et les troubles de l'équilibre augmentent le risque de chutes."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles affecter la santé mentale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la douleur chronique et la perte de fonction peuvent mener à l'anxiété et à la dépression."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une approche multidisciplinaire incluant médecins, physiothérapeutes et psychologues est essentielle."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le diabète, l'alcoolisme, les infections et les maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "L'hérédité joue-t-elle un rôle ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines neuropathies sont héréditaires et peuvent être transmises dans les familles."
}
},
{
"@type": "Question",
"name": "Le vieillissement est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement augmente le risque de développer des neuropathies myélinisées."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles un risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme la sclérose en plaques augmentent le risque de neuropathies."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 04/05/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Krasnov Research Institute of Eye Diseases, Moscow, Russia.
Sechenov First Moscow State Medical University, Moscow, Russia.
Publications dans "Neurofibres myélinisées" :
3 publications dans cette catégorie
Affiliations :
Krasnov Research Institute of Eye Diseases, Moscow, Russia.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China.
NHC Key Laboratory of Myopia (Fudan University), Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
Shanghai Research Center of Ophthalmology and Optometry, Shanghai, China.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China.
NHC Key Laboratory of Myopia (Fudan University), Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
Shanghai Research Center of Ophthalmology and Optometry, Shanghai, China.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Institute of Neuroscience and Medicine (INM-1), Forschungszentrum Jülich GmbH, 52425, Jülich, Germany.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Department of Ophthalmology, EYE & ENT Hospital of Fudan University, 19 Baoqing Road, Shanghai, 200031, China.
NHC Key Laboratory of Myopia (Fudan University), Shanghai, China.
Shanghai Research Center of Ophthalmology and Optometry, Shanghai, China.
Shanghai Engineering Research Center of Laser and Autostereoscopic 3D for Vision Care, Shanghai, China.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Department of Eye Center, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China (Q.Z.).
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Department of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Department of Medical Physics, University College London, Gower Street, London WC1E 6BT, United Kingdom.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Department of Neural Sciences, Temple University, Philadelphia, United States.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Department of Neural Sciences, Temple University, Philadelphia, United States.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Department of Neural Sciences, Temple University, Philadelphia, United States.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacology and Toxicology, Augusta University, Augusta, United States.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacology and Toxicology, Augusta University, Augusta, United States.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Department of Neural Sciences, Temple University, Philadelphia, United States.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands.
Laboratory of BioNanoTechnology, Wageningen University & Research, Bornse Weilanden 9, 6708 WG Wageningen, The Netherlands.
Publications dans "Neurofibres myélinisées" :
1 publication dans cette catégorie
Affiliations :
Department of Neurology, RWTH Aachen University Hospital, Pauwelsstrasse 30, 52074 Aachen, Germany.
Publications dans "Neurofibres myélinisées" :
Neuropsychology is important in differential diagnosis, treatment planning, surgical work-up, and support of patients with movement disorders and their families. The cognitive profiles of several move...
On the basis of both scientific progress and popular lore, there is growing optimism in the therapeutic potential of cannabis (marijuana) and cannabinoid-based chemicals for movement disorders. There ...
In recognition of the high interest and controversial nature of this subject, the meeting committee of the International Parkinson and Movement Disorders Society arranged for a talk on cannabis at the...
The endocannabinoid system is strongly tied to motor function and dysfunction, with basic research suggesting several promising therapeutic targets related to cannabinoids for movement disorders. Clin...
Further research is greatly needed to better understand the actual clinical benefits and long-term side effects of medical cannabis products for movement disorders indications and populations....
Functional movement disorder (FMD) is a complex neuropsychiatric syndrome, encompassing abnormal movements and weakness, and is a common cause of potentially disabling neurological symptoms. It is vit...
Motor symptoms in functional movement disorders (FMDs) are experienced as involuntary but share characteristics of voluntary action. Clinical and experimental evidence indicate alterations in monitori...
The objective of this study was to test the prediction that FMDs are associated with a reduced ability to make accurate (metacognitive) judgments about self-performed movements....
We compared 24 patients with FMD (including functional gait disturbance, functional tremor, and functional tics) with 24 age- and sex-matched healthy control subjects in a novel visuomotor-metacogniti...
Patients and control subjects showed comparable motor performance, response accuracy, and use of the confidence scale. However, visuomotor sensitivity in the trajectory judgment was reduced in patient...
Patients with FMD exhibited deficits both when making visuomotor decisions about their own movements and in the metacognitive evaluation of these decisions. Reduced metacognitive insight into voluntar...
The purpose of this review is to outline the impact of the COVID-19 pandemic on movement disorder holistic care, particularly in the care of people with Parkinson disease (PWP)....
As the pandemic unfolds, a flurry of literature was published regarding the impact of COVID-19 on people with Parkinson disease including the direct impact of infection, availability of ambulatory car...
COVID-19 has impacted the care of PWP in numerous ways. Recognizing infection in PWP poses challenges. Specific long-term complications, including emerging reports of long COVID syndrome is a growing ...
Drug-induced movement disorders (DIMDs) are most commonly associated with typical and atypical antipsychotics. However, other drugs such as antidepressants, antihistamines, antiepileptics, antiarrhyth...
Post-stroke movement disorders (PSMD) encompass a wide array of presentations, which vary in mode of onset, phenomenology, response to treatment, and natural history. There are no evidence-based guide...
To survey current opinions and practices on the diagnosis and treatment of PSMD....
A survey was developed by the PSMD Study Group, commissioned by the International Parkinson's and Movement Disorders Society (MDS). The survey, distributed to all members, yielded a total of 529 respo...
Parkinsonism (68%), hemiballismus/hemichorea (61%), tremor (58%), and dystonia (54%) were by far the most commonly endorsed presentation of PSMD, although this varied by region. Basal ganglia stroke (...
Regionally varying opinions and practices on PSMD highlight gaps in (and mistranslation of) epidemiologic and therapeutic knowledge. Multicenter registries and prospective community-based studies are ...
The relationship between antiseizure drugs and movement disorders is complex and not adequately reviewed so far. Antiseizure drugs as a treatment for tremor and other entities such as myoclonus and re...
Hereditary or familial spastic paraplegias (SPG) comprise a group of genetically and phenotypically heterogeneous diseases characterized by progressive degeneration of the corticospinal tracts. The co...
To summarize the clinical descriptions of SPG that manifest with movement disorders or ataxias to assist the clinician in the task of diagnosing these diseases....
We conducted a narrative review of the literature, including case reports, case series, review articles and observational studies published in English until December 2022....
Juvenile or early-onset parkinsonism with variable levodopa-responsiveness have been reported, mainly in SPG7 and SPG11. Dystonia can be observed in patients with SPG7, SPG11, SPG22, SPG26, SPG35, SPG...
Patients with SPG may present with different forms of movement disorders such as parkinsonism, dystonia, tremor, myoclonus and ataxia. The specific movement disorder in the clinical manifestation of a...
Peripherally-induced movement disorders (PIMD) should be considered when involuntary or abnormal movements emerge shortly after an injury to a body part. A close topographic and temporal association b...
A comprehensive PubMed search through a broad range of keywords and combinations was performed in February 2023 to identify relevant articles for this narrative review....
The spectrum of the phenomenology of PIMD is broad and it encompasses both hyperkinetic and hypokinetic movements. Hemifacial spasm is probably the most common PIMD. Others include dystonia, tremor, p...
There is considerable heterogeneity among PIMD in terms of severity and nature of injury, natural course, association with pain, and response to treatment. As some patients may have co-existing functi...